Rtw Investments 13F: Adds $128M to Hinge Health (HNGE) Stake

RTW Investments has significantly increased its stake in Hinge Health, Inc. (NYSE: HNGE), according to a recent filing. The investment firm boosted its holdings by 1,576,500 shares, a 446% increase, bringing its total to 1,930,000 shares. This position is valued at approximately $125.97 million as of the filing date on May 15, 2026.

What Changed in RTW Investments' Hinge Health Position

RTW Investments' latest move marks a substantial increase in its investment in Hinge Health. Previously holding 353,500 shares, the firm added 1,576,500 shares to its portfolio, resulting in a total of 1,930,000 shares. This increase reflects a 446% growth in their stake, underscoring their confidence in the company.

Other Institutional Activity in Hinge Health

Several other funds have also made notable moves in Hinge Health. Insight Holdings Group, LLC maintained its position with 9,375,164 shares valued at about $361.51 million. Deer Management Co. LLC added 2,633,707 shares, ending with the same amount worth $101.56 million. Meanwhile, Bit Capital GmbH reduced its holdings by 1,006,304 shares, leaving it with 2,309,797 shares valued at $89.07 million.

Hinge Health, Inc. Stock Down 22.4%

Shares of NYSE:HNGE traded near $65.27. Hinge Health has a market cap of $5.06 billion and a forward P/E ratio of 20.04. The stock's 52-week low stands at $30.08, with a high of $66.90. Its 50-day moving average is $50.53, and the 200-day moving average is $47.62. The company maintains a current ratio of 1.303 and a quick ratio of 1.039, with a debt-to-equity ratio of 2.237.

Recent Earnings

In its recent earnings report, Hinge Health posted revenue of $646.34 million, reflecting a growth rate of 47.2%. Despite this growth, the company reported a net margin of -78.95% and a return on equity of -136.00%. The company is expected to announce its next earnings on May 5, 2026.

Insider Buying and Selling at Hinge Health, Inc.

Insider activity at Hinge Health saw Gabriel M.I. Mecklenburg engaging in multiple transactions. On June 5, 2026, Mecklenburg bought and sold 50,000 shares, with some sales planned under Rule 10b5-1. Additionally, on June 1, 2026, Mecklenburg sold 83,334 shares at an average price of $60.22, with some sales planned. Kristina Leslie purchased 3,837 shares at $52.12 on June 3, 2026.

Analysts Set New Price Targets

Analysts have maintained positive outlooks on Hinge Health. On June 12, 2026, Keybanc maintained a 'buy' rating with a price target of $90. RBC Capital and Truist Securities also maintained 'buy' ratings with targets of $75 and $85, respectively, on June 11, 2026. The consensus among 15 analysts is a 'buy' recommendation, with a mean price target of $76.80.

About Hinge Health

Hinge Health, Inc. is a healthcare technology company headquartered in San Francisco, California. It focuses on developing scalable solutions for musculoskeletal (MSK) care, addressing conditions like acute injuries, chronic pain, and post-surgical recovery. Utilizing AI-powered motion tracking and a proprietary electrical nerve stimulation device, Hinge Health primarily serves self-insured employers. Founded in 2012, the company is led by CEO Daniel A. Perez and employs over 1,400 people.

Bottom Line

RTW Investments' decision to significantly increase its stake in Hinge Health reflects a strong vote of confidence in the company's prospects. With a significant market presence and continued analyst support, Hinge Health remains a closely watched player in the healthcare technology sector. As a reminder, 13F filings like this one provide a historical snapshot of holdings and may not represent current positions.